SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsBiotechnology Equipment

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2123823

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2123823

Blood Culture Tests Market by Product (Consumables, Instruments), Method (Manual, Automated), Technology (Culture-Based, Molecular, Proteomics), Application (Bacteremia, Fungemia), End User (Hospital, Academic Research), Region - Global Forecast to 2031

PUBLISHED:
PAGES: 372 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The global blood culture tests market is anticipated to grow from USD 6.66 billion in 2026 to USD 8.94 billion by 2031, reflecting a CAGR of 6.1%. Market growth is supported by the rising incidence of bloodstream infections (BSIs), sepsis, and healthcare-associated infections (HAIs), along with increasing concerns regarding antimicrobial resistance (AMR). Blood culture remains an important diagnostic approach for detecting viable microorganisms in the bloodstream and supporting appropriate antimicrobial treatment decisions.

Scope of the Report
Years Considered for the Study2026-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsProduct, Method, Technology, Application, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

The increasing number of hospital admissions, surgical procedures, and critically ill and immunocompromised patients is further contributing to blood culture testing volumes. Additionally, the growing adoption of automated blood culture systems, rapid microbial identification technologies, and integrated microbiology workflows, coupled with expanding diagnostic laboratory infrastructure, is accelerating market growth.

Blood Culture Tests Market - IMG1

"Consumables to register the highest CAGR in the blood culture tests market from 2026 to 2031"

Based on product, the consumables segment is likely to record the highest CAGR during the forecast period. This segment is primarily driven by the recurring utilization of blood culture bottles, culture media, reagents, and other associated consumables required for routine blood culture testing. Unlike instruments, which are generally capital purchases with relatively long replacement cycles, blood culture bottles and related consumables are required for each test, creating sustained demand in proportion to testing volumes. Increasing diagnosis of sepsis and bloodstream infections, rising hospital and critical care admissions, and greater emphasis on early identification of causative pathogens are contributing to higher consumption across hospital microbiology and diagnostic laboratories. Furthermore, the expanding installed base of automated blood culture platforms is generating recurring demand for compatible aerobic, anaerobic, and pediatric blood culture bottles and media, further strengthening the segment's position in the global market.

"Bacteremia segment captured the largest share of the blood culture tests market in 2025"

Based on application, the bacteremia segment accounted for the largest market share in 2025, owing to the widespread use of blood cultures for the detection of bacterial bloodstream infections and identification of causative pathogens. Bacteremia can occur secondary to infections originating from the respiratory tract, urinary tract, gastrointestinal tract, skin and soft tissues, as well as from intravascular catheters and other invasive procedures, resulting in substantial testing demand across hospital settings. Blood culture remains a key diagnostic method for confirming viable bacteria in the bloodstream and obtaining isolates for subsequent pathogen identification and antimicrobial susceptibility testing (AST).

"Asia Pacific to register fastest growth rate in blood culture tests market between 2026 and 2031"

Based on region, Asia Pacific is expected to witness the fastest growth rate during the forecast period. The regional market growth is supported by expanding healthcare infrastructure, increasing healthcare expenditure, and continued development of hospital and clinical laboratory capabilities across emerging economies. The substantial burden of infectious diseases, bloodstream infections, sepsis, and healthcare-associated infections, coupled with large patient populations and increasing hospital admissions, is driving demand for blood culture testing across the region. Governments and private healthcare providers are investing in diagnostic laboratory infrastructure, microbiology capabilities, hospital capacity, and healthcare accessibility, supporting a gradual transition from conventional workflows toward automated blood culture systems in several markets. Furthermore, growing awareness of antimicrobial resistance, antimicrobial stewardship, and the importance of early pathogen identification, along with increasing adoption of automated microbiology platforms and rapid diagnostic technologies, is contributing to market expansion. Major countries supporting regional growth include China, India, Japan, South Korea, and other rapidly developing Asia Pacific healthcare markets.

Breakdown of primary participants in the blood culture tests market is as follows:

  • By Company Type: Tier 1 (31%), Tier 2 (40%), and Tier 3 (29%)
  • By Designation: C-level Executives (30%), Directors (24%), and Others (46%)
  • By Region: North America (52%), Europe (20%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%)

Key players in the blood culture tests market are Waters Corporation (US), bioMerieux (France), Thermo Fisher Scientific, Inc. (US), DiaSorin S.p.A. (Italy), Danaher Corporation (US), Bruker Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Accelerate Diagnostics, Inc (US), and Autobio Diagnostics Co., Ltd (China).

Research Coverage:

This research report categorizes the blood culture tests market by product (consumables, instruments, and software & services), method (conventional/manual blood culture and automated blood culture), technology (culture-based, molecular, and proteomics), application (bacteremia, fungemia, and mycobacterial detection), end user (hospital laboratories, reference laboratories, academic research laboratories, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the blood culture tests market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, solutions, and key strategies, such as partnerships, collaborations, expansions, agreements, product launches, and recent developments in the market. This report covers the competitive analysis of upcoming startups in the blood culture tests ecosystem.

Reasons to Buy This Report:

The report will help leaders/new entrants in this market by providing information on the closest approximations of revenue for the overall blood culture tests market and its subsegments. This report will help stakeholders understand the competitive landscape and gain deeper insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

  • Analysis of key drivers (Increasing number of sepsis patients and cost of treatment, Rapid growth in geriatric population with chronic diseases, High incidence of nosocomial bloodstream infections, Growing demand for rapid diagnostic techniques with faster turnaround times, High prevalence of infectious diseases globally), restraints (High cost of automated blood culture instruments, Lack of trained laboratory technicians) opportunities (Growth opportunities in emerging economies, Increased need to identify antibiotic-resistant microorganisms) and Challenges (Long turnaround time associated with conventional blood culture workflows, Blood culture contamination and pre-analytical errors) influencing the blood culture tests market growth
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the blood culture tests market
  • Market Development: Comprehensive information about lucrative markets; the report analyzes the blood culture tests market across varied regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the blood culture tests market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Waters Corporation (US), bioMerieux (France), Thermo Fisher Scientific, Inc. (US), and DiaSorin S.p.A. (Italy)
Show more
Product Code: MD 3252

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: INSIGHTS & STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
  • 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
  • 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 BLOOD CULTURE TESTS MARKET OVERVIEW
  • 3.2 BLOOD CULTURE TESTS MARKET, BY OFFERING, 2026 VS. 2031
  • 3.3 BLOOD CULTURE TESTS MARKET, BY METHOD, 2026 VS. 2031
  • 3.4 BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2026 VS. 2031
  • 3.5 BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2026 VS. 2031
  • 3.6 BLOOD CULTURE TESTS MARKET, BY END USER, 2026 VS. 2031
  • 3.7 BLOOD CULTURE TESTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Increasing number of sepsis patients and rising cost of treatment
      • 4.2.1.2 Rapid growth in geriatric population with chronic diseases
      • 4.2.1.3 High incidence of bloodstream infections
      • 4.2.1.4 Growing demand for rapid diagnostic techniques
      • 4.2.1.5 High prevalence of infectious diseases
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 High cost of automated blood culture instruments
      • 4.2.2.2 Lack of trained laboratory technicians
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Growth opportunities in emerging economies
      • 4.2.3.2 Increased need to identify antibiotic-resistant microorganisms
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Long turnaround time associated with conventional blood culture workflows
      • 4.2.4.2 Blood culture contamination and pre-analytical errors
  • 4.3 UNMET NEEDS & WHITE SPACES
    • 4.3.1 UNMET NEEDS IN BLOOD CULTURE TESTS MARKET
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
    • 4.5.1 KEY MOVES & STRATEGIC FOCUS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 BARGAINING POWER OF SUPPLIERS
    • 5.1.2 BARGAINING POWER OF BUYERS
    • 5.1.3 THREAT OF NEW ENTRANTS
    • 5.1.4 THREAT OF SUBSTITUTES
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS & FORECAST
  • 5.3 SUPPLY CHAIN ANALYSIS
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
    • 5.5.1 BLOOD CULTURE TESTS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • 5.6 PRICING ANALYSIS
    • 5.6.1 AVERAGE SELLING PRICE OF BLOOD CULTURE TEST PRODUCTS, BY KEY PLAYER, 2024-2026
    • 5.6.2 AVERAGE SELLING PRICE OF BLOOD CULTURE TEST PRODUCTS, BY REGION, 2024-2026
  • 5.7 TRADE ANALYSIS
    • 5.7.1 IMPORT SCENARIO (HS CODE 382100)
    • 5.7.2 EXPORT SCENARIO (HS CODE 382100)
  • 5.8 KEY CONFERENCES & EVENTS, 2026-2027
  • 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.10 INVESTMENT & FUNDING SCENARIO
  • 5.11 CASE STUDY ANALYSIS
    • 5.11.1 ENHANCED STAINING AND WORKFLOW PROTOCOLS IMPROVE DETECTION OF FASTIDIOUS ORGANISMS IN POSITIVE BLOOD CULTURES
    • 5.11.2 RAPID BLOOD CULTURE IDENTIFICATION AND ANTIMICROBIAL STEWARDSHIP REDUCE TIME TO OPTIMAL THERAPY
  • 5.12 IMPACT OF 2025 US TARIFFS ON BLOOD CULTURE TESTS MARKET
    • 5.12.1 INTRODUCTION
    • 5.12.2 KEY TARIFF RATES
    • 5.12.3 PRICE IMPACT ANALYSIS
    • 5.12.4 IMPACT ON REGION
      • 5.12.4.1 North America
      • 5.12.4.2 Europe
      • 5.12.4.3 Asia Pacific
    • 5.12.5 IMPACT ON END-USE INDUSTRIES
      • 5.12.5.1 Hospital laboratories
      • 5.12.5.2 Reference laboratories
      • 5.12.5.3 Academic research laboratories
      • 5.12.5.4 Other end users

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 KEY TECHNOLOGIES
    • 6.1.1 CULTURE-BASED TECHNOLOGIES
    • 6.1.2 MOLECULAR TECHNOLOGIES
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTING
  • 6.3 TECHNOLOGY/PRODUCT ROADMAP
  • 6.4 PATENT ANALYSIS
    • 6.4.1 LIST OF MAJOR PATENTS
  • 6.5 FUTURE APPLICATIONS
  • 6.6 IMPACT OF AI/GENERATIVE AI ON BLOOD CULTURE TESTS MARKET
    • 6.6.1 INTRODUCTION
    • 6.6.2 TOP USE CASES & MARKET POTENTIAL
    • 6.6.3 KEY COMPANIES IMPLEMENTING AI
    • 6.6.4 FUTURE OF AI

7 SUSTAINABILITY & REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS & COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 INDUSTRY STANDARDS
  • 7.2 SUSTAINABILITY INITIATIVES
    • 7.2.1 ENVIRONMENTAL IMPACT & ECO-FRIENDLY INITIATIVES IN BLOOD CULTURE TESTS
      • 7.2.1.1 Eco-friendly initiatives
  • 7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS ACROSS VARIOUS END USERS
  • 8.5 MARKET PROFITABILITY
    • 8.5.1 REVENUE POTENTIAL
    • 8.5.2 COST DYNAMICS
    • 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

9 BLOOD CULTURE TESTS MARKET, BY OFFERING

  • 9.1 INTRODUCTION
  • 9.2 CONSUMABLES
    • 9.2.1 BLOOD CULTURE MEDIA
      • 9.2.1.1 Aerobic blood culture media
        • 9.2.1.1.1 Growing blood culture volumes to support aerobic media market growth
      • 9.2.1.2 Pediatric aerobic blood culture media
        • 9.2.1.2.1 Rising pediatric sepsis burden to drive demand for specialized low-volume blood culture bottles
      • 9.2.1.3 Anaerobic blood culture media
        • 9.2.1.3.1 Increased need for routine diagnosis of bacteria in blood culture to drive segment
      • 9.2.1.4 Mycobacterial blood culture media
        • 9.2.1.4.1 Persistent global TB burden to drive demand for mycobacterial blood culture media
      • 9.2.1.5 Fungi/yeast blood culture media
        • 9.2.1.5.1 Easy identification and characterization of special fungal species to drive segment
    • 9.2.2 ASSAY KITS & REAGENTS
      • 9.2.2.1 Increased need for rapid identification of bacteria and yeast from positive blood cultures to drive market
    • 9.2.3 BLOOD CULTURE ACCESSORIES
      • 9.2.3.1 Growing number of blood culture tests to drive market
  • 9.3 INSTRUMENTS
    • 9.3.1 AUTOMATED BLOOD CULTURE SYSTEMS
      • 9.3.1.1 Need for automated imaging systems and advanced algorithms to drive market
    • 9.3.2 SUPPORTING LABORATORY EQUIPMENT
      • 9.3.2.1 Incubators
        • 9.3.2.1.1 Incubators to provide optimal environment with adequate temperature and oxygen levels for microbial growth
      • 9.3.2.2 Colony counters
        • 9.3.2.2.1 Colony counters to increase direct image scanning and analysis capability
      • 9.3.2.3 Microscopes
        • 9.3.2.3.1 Growing emphasis on rapid preliminary identification to fuel demand for microscopes
      • 9.3.2.4 Gram stainers
        • 9.3.2.4.1 Gram strainers to guide initial antibiotic section and appropriate empirical therapy
      • 9.3.2.5 Other supporting equipment
  • 9.4 SOFTWARE & SERVICES
    • 9.4.1 INCREASED NEED FOR AUTOMATED SYSTEMS IN HOSPITAL-BASED LABORATORIES TO DRIVE MARKET

10 BLOOD CULTURE TESTS MARKET, BY METHOD

  • 10.1 INTRODUCTION
  • 10.2 CONVENTIONAL/MANUAL BLOOD CULTURES
    • 10.2.1 LOWER CAPITAL REQUIREMENTS TO DRIVE ADOPTION OF CONVENTIONAL BLOOD CULTURE METHODS IN RESOURCE-CONSTRAINED SETTINGS
  • 10.3 AUTOMATED BLOOD CULTURES
    • 10.3.1 NEED FOR FASTER TURNAROUND TIMES TO FUEL TRANSITION TOWARD AUTOMATED BLOOD CULTURE METHODS

11 BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY

  • 11.1 INTRODUCTION
  • 11.2 CULTURE-BASED TECHNOLOGIES
    • 11.2.1 ADVANCEMENTS IN AUTOMATED DETECTION TO STRENGTHEN CULTURE-BASED TECHNOLOGIES SEGMENT
  • 11.3 MOLECULAR TECHNOLOGIES
    • 11.3.1 PCR
      • 11.3.1.1 Reduced risk of contamination and easy detection of bloodstream infections to drive segment
    • 11.3.2 MICROARRAYS
      • 11.3.2.1 Determination of better genotyping characterization and identification of bacterial infections to drive segment
    • 11.3.3 PNA-FISH
      • 11.3.3.1 Rapid species-level identification to strengthen role of PNA-FISH in bloodstream infection diagnosis
  • 11.4 OTHER TECHNOLOGIES

12 BLOOD CULTURE TESTS MARKET, BY APPLICATION

  • 12.1 INTRODUCTION
  • 12.2 BACTEREMIA
    • 12.2.1 GROWING INCIDENCE OF SEPSIS CASES GLOBALLY TO DRIVE MARKET
  • 12.3 FUNGEMIA
    • 12.3.1 INCREASING INCIDENCE OF BLOODSTREAM INFECTIONS TO DRIVE MARKET
  • 12.4 MYCOBACTERIAL DETECTION
    • 12.4.1 HIGH GLOBAL TB BURDEN AND CONCENTRATION OF CASES IN HIGH-RISK POPULATIONS TO DRIVE DEMAND

13 BLOOD CULTURE TESTS MARKET, BY END USER

  • 13.1 INTRODUCTION
  • 13.2 HOSPITAL LABORATORIES
    • 13.2.1 INCREASED ABILITY TO CONDUCT LARGE VOLUME OF BLOOD CULTURE TESTS TO DRIVE MARKET
  • 13.3 REFERENCE LABORATORIES
    • 13.3.1 GROWING REFERRAL AND SPECIALIZED TESTING NEEDS TO FUEL REFERENCE LABORATORY DEMAND
  • 13.4 ACADEMIC RESEARCH LABORATORIES
    • 13.4.1 GROWING FOCUS ON NOVEL DIAGNOSTIC DEVELOPMENT TO FUEL BLOOD CULTURE TESTING IN RESEARCH LABORATORIES
  • 13.5 OTHER END USERS

14 BLOOD CULTURE TESTS MARKET, BY REGION

  • 14.1 INTRODUCTION
  • 14.2 NORTH AMERICA
    • 14.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
    • 14.2.2 US
      • 14.2.2.1 Rising sepsis burden and antimicrobial resistance to drive demand for blood culture testing in US
    • 14.2.3 CANADA
      • 14.2.3.1 Increasing MRSA bloodstream infection burden to strengthen demand
  • 14.3 BLOOD CULTURE TESTS MARKET: VOLUME ANALYSIS
    • 14.3.1 INTRODUCTION
    • 14.3.2 NORTH AMERICA: BLOOD CULTURE SETS VOLUME
  • 14.4 EUROPE
    • 14.4.1 EUROPE: MACROECONOMIC OUTLOOK
    • 14.4.2 GERMANY
      • 14.4.2.1 Expanding healthcare investment and inpatient care spending to drive adoption
    • 14.4.3 UK
      • 14.4.3.1 Rising AMR-related bacteremia and E. coli prevalence to expand blood culture testing
    • 14.4.4 FRANCE
      • 14.4.4.1 Rising healthcare expenditure and high physician density to strengthen adoption
    • 14.4.5 ITALY
      • 14.4.5.1 Expanding microbiology surveillance and continued healthcare investment to support Italy's market
    • 14.4.6 SPAIN
      • 14.4.6.1 Growing elderly population and healthcare utilization to sustain demand
    • 14.4.7 REST OF EUROPE
  • 14.5 ASIA PACIFIC
    • 14.5.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
    • 14.5.2 CHINA
      • 14.5.2.1 Expanding healthcare investment and hospital capacity to drive blood culture testing demand in China
    • 14.5.3 JAPAN
      • 14.5.3.1 Extensive hospital infrastructure to sustain demand
    • 14.5.4 INDIA
      • 14.5.4.1 Rising government healthcare expenditure to support expansion of diagnostic and laboratory infrastructure
    • 14.5.5 REST OF ASIA PACIFIC
  • 14.6 LATIN AMERICA
    • 14.6.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
    • 14.6.2 BRAZIL
      • 14.6.2.1 Growth in hospital-service expenditure to support modernization of Brazil's clinical diagnostic infrastructure
    • 14.6.3 MEXICO
      • 14.6.3.1 Strengthening AMR laboratory requirements to support adoption
    • 14.6.4 REST OF LATIN AMERICA
  • 14.7 MIDDLE EAST & AFRICA
    • 14.7.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK

15 COMPETITIVE LANDSCAPE

  • 15.1 INTRODUCTION
  • 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 15.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN BLOOD CULTURE TESTS MARKET
  • 15.3 REVENUE ANALYSIS, 2023-2025
  • 15.4 MARKET SHARE ANALYSIS, 2025
  • 15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 15.5.1 STARS
    • 15.5.2 EMERGING LEADERS
    • 15.5.3 PERVASIVE PLAYERS
    • 15.5.4 PARTICIPANTS
    • 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 15.5.5.1 Company footprint
      • 15.5.5.2 Region footprint
      • 15.5.5.3 Offering footprint
      • 15.5.5.4 Method footprint
      • 15.5.5.5 Technology footprint
  • 15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 15.6.1 PROGRESSIVE COMPANIES
    • 15.6.2 RESPONSIVE COMPANIES
    • 15.6.3 DYNAMIC COMPANIES
    • 15.6.4 STARTING BLOCKS
    • 15.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
      • 15.6.5.1 Detailed list of key startups/SMEs
      • 15.6.5.2 Competitive benchmarking of startups/SMEs (1/2)
      • 15.6.5.3 Competitive benchmarking of startups/SMEs (2/2)
  • 15.7 COMPANY VALUATION & FINANCIAL METRICS
    • 15.7.1 FINANCIAL METRICS
    • 15.7.2 COMPANY VALUATION
  • 15.8 BRAND/PRODUCT COMPARISON
  • 15.9 COMPETITIVE SCENARIO
    • 15.9.1 PRODUCT LAUNCHES & APPROVALS
    • 15.9.2 DEALS

16 COMPANY PROFILES

  • 16.1 KEY PLAYERS
    • 16.1.1 WATERS CORPORATION
      • 16.1.1.1 Business overview
      • 16.1.1.2 Products offered
      • 16.1.1.3 Recent developments
        • 16.1.1.3.1 Product approvals
        • 16.1.1.3.2 Deals
      • 16.1.1.4 MnM view
        • 16.1.1.4.1 Right to win
        • 16.1.1.4.2 Strategic choices
        • 16.1.1.4.3 Weaknesses & competitive threats
    • 16.1.2 BIOMERIEUX
      • 16.1.2.1 Business overview
      • 16.1.2.2 Products offered
      • 16.1.2.3 Recent developments
        • 16.1.2.3.1 Product launches
      • 16.1.2.4 MnM view
        • 16.1.2.4.1 Right to win
        • 16.1.2.4.2 Strategic choices
        • 16.1.2.4.3 Weaknesses & competitive threats
    • 16.1.3 THERMO FISHER SCIENTIFIC, INC.
      • 16.1.3.1 Business overview
      • 16.1.3.2 Products offered
      • 16.1.3.3 Recent developments
        • 16.1.3.3.1 Deals
      • 16.1.3.4 MnM view
        • 16.1.3.4.1 Right to win
        • 16.1.3.4.2 Strategic choices
        • 16.1.3.4.3 Weaknesses & competitive threats
    • 16.1.4 DANAHER CORPORATION
      • 16.1.4.1 Business overview
      • 16.1.4.2 Products offered
      • 16.1.4.3 MnM view
        • 16.1.4.3.1 Right to win
        • 16.1.4.3.2 Strategic choices
        • 16.1.4.3.3 Weaknesses & competitive threats
    • 16.1.5 F. HOFFMANN-LA ROCHE LTD.
      • 16.1.5.1 Business overview
      • 16.1.5.2 Products offered
      • 16.1.5.3 Recent developments
        • 16.1.5.3.1 Product launches
      • 16.1.5.4 MnM view
        • 16.1.5.4.1 Right to win
        • 16.1.5.4.2 Strategic choices
        • 16.1.5.4.3 Weaknesses & competitive threats
    • 16.1.6 DIASORIN S.P.A.
      • 16.1.6.1 Business overview
      • 16.1.6.2 Products offered
      • 16.1.6.3 Recent developments
        • 16.1.6.3.1 Product approvals
    • 16.1.7 BRUKER CORPORATION
      • 16.1.7.1 Business overview
      • 16.1.7.2 Products offered
      • 16.1.7.3 Recent developments
        • 16.1.7.3.1 Product launches & approvals
        • 16.1.7.3.2 Deals
    • 16.1.8 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
      • 16.1.8.1 Business overview
      • 16.1.8.2 Products offered
      • 16.1.8.3 Recent developments
        • 16.1.8.3.1 Product launches
    • 16.1.9 AUTOBIO DIAGNOSTICS CO., LTD.
      • 16.1.9.1 Business overview
      • 16.1.9.2 Products offered
      • 16.1.9.3 Recent developments
        • 16.1.9.3.1 Deals
    • 16.1.10 SCENKER BIOLOGICAL TECHNOLOGY CO., LTD.
      • 16.1.10.1 Business overview
      • 16.1.10.2 Products offered
  • 16.2 OTHER PLAYERS
    • 16.2.1 HIMEDIA LABORATORIES PVT. LTD.
    • 16.2.2 BIOBASE GROUP
    • 16.2.3 LABOTRONICS SCIENTIFIC
    • 16.2.4 HARDY DIAGNOSTICS
    • 16.2.5 BIOLOG, INC.
    • 16.2.6 ZHUHAI DEER BIOENGINEERING CO., LTD.
    • 16.2.7 ZHUHAI MEIHUA MEDICAL TECHNOLOGY CO. LTD.
    • 16.2.8 FISON INSTRUMENTS LTD.
    • 16.2.9 BINDER GMBH
    • 16.2.10 LABTRON EQUIPMENT LTD.
    • 16.2.11 LABNICS LTD.
    • 16.2.12 COPAN ITALIA S.P.A.
    • 16.2.13 GREINER BIO-ONE INTERNATIONAL GMBH
    • 16.2.14 LIOFILCHEM S.R.L.
    • 16.2.15 TITAN BIOTECH LTD.

17 RESEARCH METHODOLOGY

  • 17.1 RESEARCH DATA
  • 17.2 RESEARCH APPROACH
    • 17.2.1 SECONDARY RESEARCH
      • 17.2.1.1 Key data from secondary sources
    • 17.2.2 PRIMARY DATA
      • 17.2.2.1 Key data from primary sources
      • 17.2.2.2 Key industry insights
  • 17.3 MARKET SIZE ESTIMATION
    • 17.3.1 BOTTOM-UP APPROACH
      • 17.3.1.1 Approach 1: Company revenue estimation approach
      • 17.3.1.2 Approach 2: Presentations of companies and primary interviews
      • 17.3.1.3 Growth forecast
    • 17.3.2 TOP-DOWN APPROACH
  • 17.4 MARKET BREAKDOWN & DATA TRIANGULATION
  • 17.5 MARKET SHARE ANALYSIS
  • 17.6 RESEARCH ASSUMPTIONS
    • 17.6.1 GROWTH RATE ASSUMPTIONS
  • 17.7 RESEARCH LIMITATIONS
  • 17.8 RISK ASSESSMENT

18 APPENDIX

  • 18.1 DISCUSSION GUIDE
  • 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 18.3 CUSTOMIZATION OPTIONS
  • 18.4 RELATED REPORTS
  • 18.5 AUTHOR DETAILS
Show more
Product Code: MD 3252

List of Tables

  • TABLE 1 ESTIMATED NUMBER OF PEOPLE LIVING WITH HIV, ALL AGES, 2010, 2023, AND 2024 (MILLION PEOPLE)
  • TABLE 2 TOTAL TUBERCULOSIS INCIDENCE, BY REGION, 2024
  • TABLE 3 BLOOD CULTURE TESTS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 4 GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023-2030
  • TABLE 5 AVERAGE SELLING PRICE OF BLOOD CULTURE TEST PRODUCTS, BY KEY PLAYER, 2024-2026 (USD)
  • TABLE 6 AVERAGE SELLING PRICE OF BLOOD CULTURE TEST PRODUCTS, BY REGION, 2024-2026 (USD)
  • TABLE 7 IMPORT DATA FOR HS CODE 382100-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 8 EXPORT DATA FOR HS CODE 382100-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
  • TABLE 9 BLOOD CULTURE TESTS MARKET: KEY CONFERENCES & EVENTS, 2026-2027
  • TABLE 10 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 11 LIST OF MAJOR PATENTS PERTAINING TO BLOOD CULTURE TESTS MARKET, 2023-2025
  • TABLE 12 KEY COMPANIES IMPLEMENTING AI IN BLOOD CULTURE TESTS MARKET
  • TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 GLOBAL STANDARDS IN BLOOD CULTURE TESTS MARKET
  • TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
  • TABLE 20 KEY BUYING CRITERIA, BY OFFERING
  • TABLE 21 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • TABLE 22 BLOOD CULTURE TESTS MARKET: UNMET NEEDS ACROSS VARIOUS END USERS
  • TABLE 23 BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 24 BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 25 BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 26 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 27 EUROPE: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 28 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 29 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 30 EXAMPLES OF BLOOD CULTURE MEDIA
  • TABLE 31 BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 32 BLOOD CULTURE MEDIA MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 33 NORTH AMERICA: BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 34 EUROPE: BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 35 ASIA PACIFIC: BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 36 LATIN AMERICA: BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 37 AEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 38 NORTH AMERICA: AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 39 EUROPE: AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 40 ASIA PACIFIC: AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 41 LATIN AMERICA: AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 42 PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 43 NORTH AMERICA: PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 44 EUROPE: PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 45 ASIA PACIFIC: PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 46 LATIN AMERICA: PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 47 ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 48 NORTH AMERICA: ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 49 EUROPE: ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 50 ASIA PACIFIC: ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 51 LATIN AMERICA: ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 52 MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 53 NORTH AMERICA: MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 54 EUROPE: MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 55 ASIA PACIFIC: MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 56 LATIN AMERICA: MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 57 FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 58 NORTH AMERICA: FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 59 EUROPE: FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 61 LATIN AMERICA: FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 62 EXAMPLES OF BLOOD CULTURE ASSAY KITS & REAGENTS
  • TABLE 63 BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 64 NORTH AMERICA: BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 65 EUROPE: BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 66 ASIA PACIFIC: BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 67 LATIN AMERICA: BLOOD CULTURE ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 68 EXAMPLES OF BLOOD CULTURE ACCESSORIES
  • TABLE 69 BLOOD CULTURE ACCESSORIES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 70 NORTH AMERICA: BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 71 EUROPE: BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 73 LATIN AMERICA: BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 74 BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 75 BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 76 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 77 EUROPE: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 79 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 80 EXAMPLES OF AUTOMATED BLOOD CULTURE SYSTEMS
  • TABLE 81 AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 82 NORTH AMERICA: AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 83 EUROPE: AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 85 LATIN AMERICA: AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 86 SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 87 SUPPORTING LABORATORY EQUIPMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 88 NORTH AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 89 EUROPE: SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 90 ASIA PACIFIC: SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 91 LATIN AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 92 INCUBATORS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 93 NORTH AMERICA: INCUBATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 94 EUROPE: INCUBATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: INCUBATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 96 LATIN AMERICA: INCUBATORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 97 COLONY COUNTERS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 98 NORTH AMERICA: COLONY COUNTERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 99 EUROPE: COLONY COUNTERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: COLONY COUNTERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 101 LATIN AMERICA: COLONY COUNTERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 102 MICROSCOPES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 103 NORTH AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 104 EUROPE: MICROSCOPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: MICROSCOPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 106 LATIN AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 107 GRAM STAINERS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 108 NORTH AMERICA: GRAM STAINERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 109 EUROPE: GRAM STAINERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: GRAM STAINERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 111 LATIN AMERICA: GRAM STAINERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 112 OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 113 NORTH AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 114 EUROPE: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 115 ASIA PACIFIC: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 116 LATIN AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 117 BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 118 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 119 EUROPE: BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 120 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 121 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 122 BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 123 EXAMPLES OF CONVENTIONAL/MANUAL BLOOD CULTURE PRODUCTS
  • TABLE 124 CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 125 NORTH AMERICA: CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 126 EUROPE: CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 128 LATIN AMERICA: CONVENTIONAL/MANUAL BLOOD CULTURES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 129 EXAMPLES OF AUTOMATED BLOOD CULTURE PRODUCTS
  • TABLE 130 AUTOMATED BLOOD CULTURES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 131 NORTH AMERICA: AUTOMATED BLOOD CULTURES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 132 EUROPE: AUTOMATED BLOOD CULTURES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: AUTOMATED BLOOD CULTURES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 134 LATIN AMERICA: AUTOMATED BLOOD CULTURES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 135 BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 136 BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 137 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 138 EUROPE: BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 140 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 141 BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 142 BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 143 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 144 EUROPE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 146 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 147 BLOOD CULTURE TESTS MARKET FOR PCR, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 148 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR PCR, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 149 EUROPE: BLOOD CULTURE TESTS MARKET FOR PCR, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR PCR, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 151 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR PCR, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 152 BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 153 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 154 EUROPE: BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 156 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 157 BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 158 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 159 EUROPE: BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 161 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 162 EXAMPLES OF MALDI-TOF MS SYSTEMS
  • TABLE 163 BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 164 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 165 EUROPE: BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 166 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 167 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 168 BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 169 BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 170 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 171 EUROPE: BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 173 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 174 BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 175 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 176 EUROPE: BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 177 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 178 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 179 BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 180 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 181 EUROPE: BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 182 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 183 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 184 BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 185 BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 186 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 187 EUROPE: BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 188 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 189 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 190 BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 191 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 192 EUROPE: BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 193 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 194 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 195 BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 196 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 197 EUROPE: BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 198 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 199 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 200 BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 201 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 202 EUROPE: BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 203 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 204 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 205 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 206 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 207 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 208 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 209 NORTH AMERICA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 210 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 211 NORTH AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 212 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 213 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 214 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 215 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 216 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 217 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 218 US: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 219 US: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 220 US: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 221 US: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 222 US: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 223 US: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 224 US: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 225 US: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 226 US: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 227 US: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 228 CANADA: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 229 CANADA: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 230 CANADA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 231 CANADA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 232 CANADA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 233 CANADA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 234 CANADA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 235 CANADA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 236 CANADA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 237 CANADA: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 238 NORTH AMERICA: BLOOD CULTURE SETS VOLUME, 2024-2031 (MN UNITS)
  • TABLE 239 EUROPE: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 240 EUROPE: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 241 EUROPE: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 242 EUROPE: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 243 EUROPE: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 244 EUROPE: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 245 EUROPE: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 246 EUROPE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 247 EUROPE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 248 EUROPE: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 249 EUROPE: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 250 EUROPE: MACROECONOMIC INDICATORS
  • TABLE 251 GERMANY: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 252 GERMANY: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 253 GERMANY: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 254 GERMANY: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 255 GERMANY: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 256 GERMANY: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 257 GERMANY: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 258 GERMANY: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 259 GERMANY: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 260 GERMANY: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 261 UK: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 262 UK: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 263 UK: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 264 UK: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 265 UK: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 266 UK: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 267 UK: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 268 UK: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 269 UK: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 270 UK: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 271 FRANCE: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 272 FRANCE: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 273 FRANCE: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 274 FRANCE: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 275 FRANCE: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 276 FRANCE: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 277 FRANCE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 278 FRANCE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 279 FRANCE: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 280 FRANCE: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 281 ITALY: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 282 ITALY: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 283 ITALY: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 284 ITALY: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 285 ITALY: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 286 ITALY: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 287 ITALY: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 288 ITALY: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 289 ITALY: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 290 ITALY: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 291 SPAIN: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 292 SPAIN: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 293 SPAIN: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 294 SPAIN: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 295 SPAIN: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 296 SPAIN: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 297 SPAIN: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 298 SPAIN: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 299 SPAIN: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 300 SPAIN: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 301 REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 302 REST OF EUROPE: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 303 REST OF EUROPE: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 304 REST OF EUROPE: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 305 REST OF EUROPE: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 306 REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 307 REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 308 REST OF EUROPE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 309 REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 310 REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 311 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 312 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 313 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 314 ASIA PACIFIC: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 315 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 316 ASIA PACIFIC: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 317 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 318 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 319 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 320 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 321 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 322 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 323 CHINA: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 324 CHINA: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 325 CHINA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 326 CHINA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 327 CHINA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 328 CHINA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 329 CHINA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 330 CHINA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 331 CHINA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 332 CHINA: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 333 JAPAN: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 334 JAPAN: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 335 JAPAN: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 336 JAPAN: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 337 JAPAN: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 338 JAPAN: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 339 JAPAN: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 340 JAPAN: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 341 JAPAN: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 342 JAPAN: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 343 INDIA: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 344 INDIA: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 345 INDIA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 346 INDIA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 347 INDIA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 348 INDIA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 349 INDIA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 350 INDIA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 351 INDIA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 352 INDIA: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 353 REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 354 REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 355 REST OF ASIA PACIFIC: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 356 REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 357 REST OF ASIA PACIFIC: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 358 REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 359 REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 360 REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 361 REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 362 REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 363 LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 364 LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 365 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 366 LATIN AMERICA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 367 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 368 LATIN AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 369 LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 370 LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 371 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 372 LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 373 LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 374 LATIN AMERICA: MACROECONOMIC INDICATORS
  • TABLE 375 BRAZIL: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 376 BRAZIL: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 377 BRAZIL: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 378 BRAZIL: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 379 BRAZIL: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 380 BRAZIL: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 381 BRAZIL: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 382 BRAZIL: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 383 BRAZIL: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 384 BRAZIL: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 385 MEXICO: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 386 MEXICO: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 387 MEXICO: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 388 MEXICO: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 389 MEXICO: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 390 MEXICO: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 391 MEXICO: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 392 MEXICO: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 393 MEXICO: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 394 MEXICO: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 395 REST OF LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 396 REST OF LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 397 REST OF LATIN AMERICA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 398 REST OF LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 399 REST OF LATIN AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 400 REST OF LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 401 REST OF LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 402 REST OF LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 403 REST OF LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 404 REST OF LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 405 MIIDLE EAST & AFERICA: MACROECONOMIC INDICATORS
  • TABLE 406 MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
  • TABLE 407 MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET FOR COSUMABLES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 408 MIDDLE EAST & AFRICA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 409 MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 410 MIDDLE EAST & AFRICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 411 MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 412 MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 413 MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 414 MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 415 MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 416 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN BLOOD CULTURE TESTS MARKET, JANUARY 2023-AUGUST 2026
  • TABLE 417 BLOOD CULTURE TESTS MARKET: DEGREE OF COMPETITION
  • TABLE 418 BLOOD CULTURE TESTS MARKET: REGION FOOTPRINT
  • TABLE 419 BLOOD CULTURE TESTS MARKET: OFFERING FOOTPRINT
  • TABLE 420 BLOOD CULTURE TESTS MARKET: METHOD FOOTPRINT
  • TABLE 421 BLOOD CULTURE TESTS MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 422 BLOOD CULTURE TESTS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 423 BLOOD CULTURE TESTS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2)
  • TABLE 424 BLOOD CULTURE TESTS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2)
  • TABLE 425 BLOOD CULTURE TESTS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-AUGUST 2026
  • TABLE 426 BLOOD CULTURE TESTS MARKET: DEALS, JANUARY 2023-AUGUST 2026
  • TABLE 427 WATERS CORPORATION: COMPANY OVERVIEW
  • TABLE 428 WATERS CORPORATION: PRODUCTS OFFERED
  • TABLE 429 WATERS CORPORATION: PRODUCT APPROVALS, JANUARY 2023-JUNE 2026
  • TABLE 430 WATERS CORPORATION: DEALS, JANUARY 2023-JUNE 2026
  • TABLE 431 BIOMERIEUX: COMPANY OVERVIEW
  • TABLE 432 BIOMERIEUX: PRODUCTS OFFERED
  • TABLE 433 BIOMERIEUX: PRODUCT LAUNCHES, JANUARY 2023-JUNE 2026
  • TABLE 434 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
  • TABLE 435 THERMO FISHER SCIENTIFIC, INC.: PRODUCTS OFFERED
  • TABLE 436 THERMO FISHER SCIENTIFIC, INC.: DEALS, JANUARY 2023-JUNE 2026
  • TABLE 437 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 438 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 439 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
  • TABLE 440 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
  • TABLE 441 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2023-JUNE 2026
  • TABLE 442 DIASORIN S.P.A.: COMPANY OVERVIEW
  • TABLE 443 DIASORIN S.P.A.: PRODUCTS OFFERED
  • TABLE 444 DIASORIN S.P.A.: PRODUCT APPROVALS, JANUARY 2023-JUNE 2026
  • TABLE 445 BRUKER CORPORATION: COMPANY OVERVIEW
  • TABLE 446 BRUKER CORPORATION: PRODUCTS OFFERED
  • TABLE 447 BRUKER CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
  • TABLE 448 BRUKER CORPORATION: DEALS, JANUARY 2023-JUNE 2026
  • TABLE 449 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
  • TABLE 450 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED
  • TABLE 451 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2023-JUNE 2026
  • TABLE 452 AUTOBIO DIAGNOSTICS CO., LTD.: COMPANY OVERVIEW
  • TABLE 453 AUTOBIO DIAGNOSTICS CO., LTD.: PRODUCTS OFFERED
  • TABLE 454 AUTOBIO DIAGNOSTICS CO., LTD.: DEALS, JANUARY 2023-JUNE 2026
  • TABLE 455 SCENKER BIOLOGICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 456 SCENKER BIOLOGICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
  • TABLE 457 HIMEDIA LABORATORIES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 458 BIOBASE GROUP: COMPANY OVERVIEW
  • TABLE 459 LABOTRONICS SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 460 HARDY DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 461 BIOLOG, INC.: COMPANY OVERVIEW
  • TABLE 462 ZHUHAI DEER BIOENGINEERING CO., LTD.: COMPANY OVERVIEW
  • TABLE 463 ZHUHAI MEIHUA MEDICAL TECHNOLOGY CO. LTD.: COMPANY OVERVIEW
  • TABLE 464 FISON INSTRUMENTS LTD.: COMPANY OVERVIEW
  • TABLE 465 BINDER GMBH: COMPANY OVERVIEW
  • TABLE 466 LABTRON EQUIPMENT LTD.: COMPANY OVERVIEW
  • TABLE 467 LABNICS LTD.: COMPANY OVERVIEW
  • TABLE 468 COPAN ITALIA S.P.A.: COMPANY OVERVIEW
  • TABLE 469 GREINER BIO-ONE INTERNATIONAL GMBH: COMPANY OVERVIEW
  • TABLE 470 LIOFILCHEM S.R.L.: COMPANY OVERVIEW
  • TABLE 471 TITAN BIOTECH LTD.: COMPANY OVERVIEW
  • TABLE 472 BLOOD CULTURE TESTS MARKET: RISK ASSESSMENT

List of Figures

  • FIGURE 1 BLOOD CULTURE TESTS MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS
  • FIGURE 3 GLOBAL BLOOD CULTURE TESTS MARKET, 2024-2031
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN BLOOD CULTURE TESTS MARKET, 2023-2025
  • FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF BLOOD CULTURE TESTS MARKET
  • FIGURE 6 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN BLOOD CULTURE TESTS MARKET, 2026-2031
  • FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 8 RISING BURDEN OF BLOODSTREAM INFECTIONS AND ANTIMICROBIAL RESISTANCE TO DRIVE MARKET GROWTH
  • FIGURE 9 CONSUMABLES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 10 AUTOMATED BLOOD CULTURES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 11 CULTURE-BASED TECHNOLOGIES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 12 BACTEREMIA SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 13 HOSPITAL-LABORATORIES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 14 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 15 BLOOD CULTURE TESTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16 BLOOD CULTURE TESTS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 17 BLOOD CULTURE TESTS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 18 BLOOD CULTURE TESTS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 19 BLOOD CULTURE TESTS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 20 BLOOD CULTURE TESTS MARKET: TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 21 NUMBER OF DEALS & FUNDING ACTIVITIES IN BLOOD CULTURE TESTS MARKET
  • FIGURE 22 PATENT ANALYSIS FOR BLOOD CULTURE TESTS, JANUARY 2015-DECEMBER 2025
  • FIGURE 23 MARKET POTENTIAL OF AI IN BLOOD CULTURE TESTS MARKET
  • FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
  • FIGURE 25 KEY BUYING CRITERIA, BY OFFERING
  • FIGURE 26 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SNAPSHOT
  • FIGURE 27 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET SNAPSHOT
  • FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN BLOOD CULTURE TESTS MARKET, 2023-2025 (USD MILLION)
  • FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS IN BLOOD CULTURE TESTS MARKET, 2025
  • FIGURE 30 BLOOD CULTURE TESTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 31 BLOOD CULTURE TESTS MARKET: COMPANY FOOTPRINT
  • FIGURE 32 BLOOD CULTURE TESTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 33 EV/EBITDA OF KEY VENDORS
  • FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 35 BLOOD CULTURE TESTS MARKET: BRAND/PRODUCT COMPARISON FOR AUTOMATED BLOOD CULTURE SYSTEMS
  • FIGURE 36 WATERS CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 37 BIOMERIEUX: COMPANY SNAPSHOT (2025)
  • FIGURE 38 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
  • FIGURE 41 DIASORIN S.P.A.: COMPANY SNAPSHOT (2025)
  • FIGURE 42 BRUKER CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 43 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2025)
  • FIGURE 44 AUTOBIO DIAGNOSTICS CO., LTD.: COMPANY SNAPSHOT (2025)
  • FIGURE 45 BLOOD CULTURE TESTS MARKET: RESEARCH DESIGN METHODOLOGY
  • FIGURE 46 PRIMARY SOURCES
  • FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 49 GLOBAL BLOOD CULTURE TESTS MARKET: REVENUE SHARE ANALYSIS
  • FIGURE 50 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 51 TOP-DOWN APPROACH
  • FIGURE 52 DATA TRIANGULATION METHODOLOGY
  • FIGURE 53 PARAMETRIC ASSUMPTIONS
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!